Commonwealth Equity Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.54M Sell
32,593
-1,455
-4% -$478K 0.01% 911
2025
Q4
$11.9M Sell
34,048
-1,855
-5% -$627K 0.02% 805
2025
Q3
$11.6M Sell
35,903
-18,095
-34% -$5.63M 0.02% 840
2025
Q2
$21M Buy
53,998
+226
+0.4% +$90.9K 0.03% 567
2025
Q1
$23.4M Buy
53,772
+3,193
+6% +$1.28M 0.03% 505
2024
Q4
$18.7M Buy
50,579
+1,887
+4% +$790K 0.03% 556
2024
Q3
$25.3M Buy
48,692
+2,929
+6% +$1.56M 0.04% 448
2024
Q2
$24.8M Sell
45,763
-3,465
-7% -$1.83M 0.04% 428
2024
Q1
$25.5M Sell
49,228
-6,034
-11% -$3M 0.04% 413
2023
Q4
$26.1M Buy
55,262
+4,362
+9% +$2.02M 0.05% 371
2023
Q3
$22.2M Sell
50,900
-2,111
-4% -$958K 0.05% 375
2023
Q2
$23.6M Buy
53,011
+2,042
+4% +$942K 0.05% 368
2023
Q1
$23.4K Buy
50,969
+2,199
+5% +$1.05M 0.05% 347
2022
Q4
$25M Buy
48,770
+9,177
+23% +$4.66M 0.06% 310
2022
Q3
$18M Buy
39,593
+4,516
+13% +$2.16M 0.05% 368
2022
Q2
$16.9M Sell
35,077
-5,107
-13% -$2.53M 0.04% 384
2022
Q1
$19.7M Buy
40,184
+6,716
+20% +$3.07M 0.05% 372
2021
Q4
$15.5M Sell
33,468
-34
-0.1% -$14.3K 0.03% 452
2021
Q3
$12.5M Buy
33,502
+712
+2% +$271K 0.03% 490
2021
Q2
$12.5M Buy
32,790
+2,768
+9% +$1.06M 0.03% 488
2021
Q1
$10.8M Sell
30,022
-487
-2% -$157K 0.03% 494
2020
Q4
$9.8M Sell
30,509
-839
-3% -$257K 0.03% 481
2020
Q3
$8.42M Sell
31,348
-469
-1% -$126K 0.03% 491
2020
Q2
$8.37M Buy
31,817
+647
+2% +$173K 0.03% 456
2020
Q1
$7.08M Sell
31,170
-531
-2% -$145K 0.03% 448
2019
Q4
$9.57M Buy
31,701
+2,898
+10% +$797K 0.04% 421
2019
Q3
$6.92M Buy
28,803
+1,219
+4% +$334K 0.03% 490
2019
Q2
$7.78M Sell
27,584
-554
-2% -$151K 0.03% 433
2019
Q1
$8.07M Sell
28,138
-220
-0.8% -$63.6K 0.04% 405
2018
Q4
$7.45M Buy
28,358
+2,091
+8% +$575K 0.04% 394
2018
Q3
$7.2M Buy
26,267
+1,779
+7% +$462K 0.03% 425
2018
Q2
$5.83M Sell
24,488
-660
-3% -$153K 0.03% 459
2018
Q1
$5.53M Buy
25,148
+288
+1% +$67.7K 0.03% 450
2017
Q4
$5.59M Buy
24,860
+509
+2% +$108K 0.03% 443
2017
Q3
$4.62M Buy
24,351
+789
+3% +$150K 0.03% 472
2017
Q2
$4.43M Sell
23,562
-7,672
-25% -$1.38M 0.03% 481
2017
Q1
$5.17M Buy
31,234
+1,324
+4% +$211K 0.03% 409
2016
Q4
$4.3M Buy
29,910
+19
+0.1% +$2.54K 0.03% 427
2016
Q3
$3.75M Buy
29,891
+400
+1% +$51.6K 0.03% 457
2016
Q2
$3.87M Buy
29,491
+209
+0.7% +$28.6K 0.03% 424
2016
Q1
$4.07M Buy
29,282
+7,568
+35% +$1.01M 0.04% 404
2015
Q4
$3.03M Buy
21,714
+318
+1% +$43.8K 0.03% 488
2015
Q3
$3M Buy
21,396
+1,387
+7% +$208K 0.03% 456
2015
Q2
$3.28M Buy
20,009
+1,487
+8% +$238K 0.03% 454
2015
Q1
$2.86M Sell
18,522
-412
-2% -$58.7K 0.03% 486
2014
Q4
$2.38M Buy
18,934
+141
+0.8% +$17.4K 0.03% 511
2014
Q3
$2.25M Sell
18,793
-1,731
-8% -$199K 0.03% 518
2014
Q2
$2.21M Sell
20,524
-1,286
-6% -$133K 0.03% 519
2014
Q1
$2.17M Buy
21,810
+2,855
+15% +$258K 0.03% 494
2013
Q4
$1.75M Buy
18,955
+7,187
+61% +$639K 0.03% 541
2013
Q3
$984K Buy
11,768
+1,558
+15% +$134K 0.02% 734
2013
Q2
$836K Buy
+10,210
New +$764K 0.01% 754

Other funds holding ELV

Commonwealth Equity Services's ELV Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Elevance Health (ELV) stake by 4.3% in Q1 2026, selling an estimated $478K and leaving 32,593 shares worth $9.54M. The position accounts for 0.01% of the portfolio, ranked #911.

Commonwealth Equity Services first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.1M in Q4 2023. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Commonwealth Equity Services held 32,593 shares of Elevance Health worth $9.54M as of Q1 2026.
  • Commonwealth Equity Services sold 1,455 Elevance Health shares in Q1 2026, an estimated $478K.
  • Elevance Health made up 0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #911 holding.
  • Commonwealth Equity Services first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's Elevance Health position peaked at $26.1M in Q4 2023.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.